← Back to Screener
Immuron Limited American Depositary Shares (IMRN)
Price$1.41
Value ScoreA
Growth ScoreB
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-69.95%
Price vs S&P 500 (4W)24.06%
VGM Score70.61
Market Capitalization$9.38M
All Metrics
Book Value / Share (Quarterly)$0.03
P/TBV (Annual)2.21x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)111.96%
Cash Flow / Share (Quarterly)$-0.01
Price vs S&P 500 (YTD)-0.53%
Gross Margin (TTM)63.68%
Net Profit Margin (TTM)-62.14%
EPS (TTM)$-0.01
10-Day Avg Trading Volume0.80M
EPS Excl Extra (TTM)$-0.01
Revenue Growth (5Y)23.67%
EPS (Annual)$-0.02
ROI (Annual)-64.64%
Gross Margin (Annual)65.39%
Net Profit Margin (5Y Avg)-1309.47%
Cash / Share (Quarterly)$0.02
Revenue Growth QoQ (YoY)4.76%
ROA (Last FY)-51.49%
Revenue Growth TTM (YoY)14.30%
EBITD / Share (TTM)$-0.01
ROE (5Y Avg)-36.64%
Operating Margin (TTM)-63.91%
Cash Flow / Share (Annual)$-0.02
P/B Ratio1.00x
P/B Ratio (Quarterly)0.95x
Net Income / Employee (Annual)$-534,819
EV / Revenue (TTM)0.41x
Net Interest Coverage (TTM)-13.28x
ROA (TTM)-36.78%
EPS Incl Extra (Annual)$-0.02
Current Ratio (Annual)5.09x
Quick Ratio (Quarterly)6.83x
3-Month Avg Trading Volume0.42M
52-Week Price Return3.85%
Revenue / Employee (TTM)$766,663
Tangible BV / Share (Quarterly)$0.06
P/S Ratio (Annual)1.79x
Asset Turnover (Annual)0.72x
52-Week High$0.10
Operating Margin (5Y Avg)-1312.09%
EPS Excl Extra (Annual)$-0.02
Tangible BV CAGR (5Y)18.38%
26-Week Price Return-54.02%
Quick Ratio (Annual)4.19x
13-Week Price Return29.03%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)8.04x
Enterprise Value$2.20M
Revenue / Share Growth (5Y)17.18%
Asset Turnover (TTM)0.59x
Book Value / Share Growth (5Y)1.71%
Revenue / Employee (Annual)$747,211
Inventory Turnover (Annual)1.50x
Pretax Margin (Annual)-71.58%
Cash / Share (Annual)$0.01
3-Month Return Std Dev128.05%
Gross Margin (5Y Avg)72.65%
Net Income / Employee (TTM)$-476,392
ROE (Last FY)-64.64%
Net Interest Coverage (Annual)-9.10x
EPS Basic Excl Extra (Annual)$-0.02
Receivables Turnover (TTM)3.14x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.01
Receivables Turnover (Annual)4.40x
ROI (TTM)-43.95%
P/S Ratio (TTM)1.75x
Pretax Margin (5Y Avg)-1309.47%
Revenue / Share (Annual)$0.02
Tangible BV / Share (Annual)$0.06
Price vs S&P 500 (52W)7.52%
Year-to-Date Return11.11%
5-Day Price Return25.00%
EPS Normalized (Annual)$-0.02
ROA (5Y Avg)-31.16%
Net Profit Margin (Annual)-71.58%
Month-to-Date Return33.33%
EBITD / Share (Annual)$-0.02
Operating Margin (Annual)-73.34%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-36.64%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.01
P/TBV (Quarterly)2.21x
P/B Ratio (Annual)1.77x
Inventory Turnover (TTM)1.44x
Pretax Margin (TTM)-62.14%
Book Value / Share (Annual)$0.02
Price vs S&P 500 (13W)19.29%
Beta1.82x
Revenue / Share (TTM)$0.02
ROE (TTM)-43.95%
52-Week Low$0.03
vGradeA
gGradeB
mGradeB
vgmGradeB
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IMRNImmuron Limited American Depositary Shares | A | B | B | $1.41 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Immuron Ltd is a biopharmaceutical company specializing in polyclonal antibody therapeutics for gastrointestinal and enteric diseases. It markets Travelan for travelers' diarrhea prevention and Protectyn as an immune supplement, while advancing two clinical-stage candidates (IMM124-E and IMM529) toward commercialization. The company generates revenue primarily from Australia, the USA, and Canada through its hyper-immune products segment.